clinical trial · NCT07710729
A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
Novo Nordisk A/S·phase1·not yet recruiting·n = 40
OverweightObesityUBT251Oral contraceptiveAcetaminophen
brief summary
The purpose of this clinical study is to find out if UBT251 is safe and effective to be taken together with medicines, like birth control tablets, and emptying of the stomach in women not able to become pregnant living with overweight or obesity
started
Jul 17, 2026
primary completion
Apr 27, 2027
completion
Apr 27, 2027
last updated
Jul 17, 2026
official title
A Single-Centre, Open-Label Study of the Effect of UBT251 on Pharmacokinetics of an Oral Combination Contraceptive (Ethinylestradiol and Levonorgestrel) and Gastric Emptying in Women of Non-Childbearing Potential With Overweight or Obesity
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol